Disputes and regulatory enforcement

View Life Sciences by content type:

Featured Life Sciences content

Practice notes
BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
Produced in partnership with Elinor Pecsteen and Cristiana Spontoni of Jones Day (Brussels) 19th Oct
Practice notes
IntroductionPatent claims may be separated into two broad categories: product claims and process claims. Product claims and process claims are...
Read More >
Produced in partnership with Bristows LLP 16th Oct
Practice notes
This Practice Note provides an introduction to:•what is a patent?•applying for and maintaining patents•dealing with patents in agreements•patent...
Read More >
16th Oct
Practice notes
BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Practice notes
What are e-cigarettes?Electronic cigarettes (commonly known as ‘e-cigarettes’, ‘vapourisers’ or ‘vapes’) are products that can be used to consume...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
This new starter guide provides an introduction to the life sciences practice area, the legislative and regulatory framework which governs the life...
Read More >
26th Sep
Practice notes
BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
Background to medical use claimsSecond (and subsequent) medical use patent claims are specific to the pharmaceutical/biotechnology industry and are...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
25th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
25th Sep
Practice notes
This Practice Note introduces and considers the general principles that apply to the advertising and promotion of medicinal products as well as the...
Read More >
25th Sep

Most recent Disputes and regulatory enforcement content

Practice notes
CASE HUBSee further, timeline, commentary and related cases.Case factsOutlineEuropean Commission Article 101 TFEU investigation into Teva and its...
Read More >
26th Sep
Practice notes
CASE HUB See further, timeline ,commentary and related cases.Case factsOutlineCMA Article 101 TFEU/Chapter I investigation into AMCo (now Advanz...
Read More >
26th Sep
Precedents
CLAIM No: [insert claim number]IN THE HIGH COURT OF JUSTICEBUSINESS AND PROPERTY COURTS OF ENGLAND & WALESINTELLECTUAL PROPERTY LIST (ChD)[Patents...
Read More >
26th Sep
Precedents
Claim No: [insert claim number]IN THE HIGH COURT OF JUSTICEBUSINESS AND PROPERTY COURTS OF ENGLAND & WALES INTELLECTUAL PROPERTY LIST (ChD)[Patents...
Read More >
26th Sep
Precedents
CLAIM No: [insert claim number]IN THE HIGH COURT OF JUSTICEBUSINESS AND PROPERTY COURTS OF ENGLAND & WALESINTELLECTUAL PROPERTY LIST (ChD)[pATENTS...
Read More >
26th Sep
Precedents
Claim No.: [insert claim number]IN THE HIGH COURT OF JUSTICEBUSINESS AND PROPERTY COURTS OF ENGLAND & WALES INTELLECTUAL PROPERTY LIST (ChD)[pATENTS...
Read More >
26th Sep
Precedents
Claim No. [insert claim number]IN THE HIGH COURT OF JUSTICEBUSINESS AND PROPERTY COURTS OF ENGLAND & WALES INTELLECTUAL PROPERTY LIST (ChD)[pATENTS...
Read More >
26th Sep
Practice notes
In order to establish that an unauthorised use or dealing in a product or process amounts to infringement of a patent it is necessary to prove that:•a...
Read More >
26th Sep
Practice notes
Patents may be revoked, that is, taken off the register of patents, if it is decided that they are invalid in some respect. The effect of revocation...
Read More >
26th Sep
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
26th Sep
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
26th Sep
Practice notes
This key issues Practice Note aims to provide a checklist of practical matters to consider before starting patent infringement litigation in the...
Read More >
26th Sep
Practice notes
Introduction to infringementA patent owner has to prove two elements before it can secure an infringement finding (and then an injunction, damages,...
Read More >
26th Sep
Practice notes
ObviousnessGeneral principles on obviousnessIn order to obtain and keep a patent, it is not enough that the invention is new because no-one else had...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes
This Practice Note looks at loss of privilege in civil litigation in the context of legal professional privilege (LPP) and in particular considers the...
Read More >
26th Sep
Practice notes
CASE HUBSee further, timeline, commentary and related cases.Case factsOutlineCMA Article 102 TFEU/Chapter II investigation into Advanz Pharma...
Read More >
26th Sep
Practice notes
CASE HUBSee further, timeline, commentary and related cases.Case factsOutlineCMA Article 101 TFEU/Chapter I and Article 102 TFEU/Chapter II...
Read More >
26th Sep
Practice notes
ARCHIVED–this archived case hub reflects the position at the date of the judgment of 10 March 2020; it is no longer maintained.See further,...
Read More >
26th Sep

Popular documents